dr. pagel on ongoing research with btk inhibitors in cll
Published 4 years ago • 95 plays • Length 2:20Download video MP4
Download video MP3
Similar videos
-
1:33
dr. woyach on ongoing research with btk inhibitors in cll
-
1:55
dr. pagel on the elevate-tn trial in cll
-
3:25
btk inhibitors in cll: treatment selection
-
1:15
dr. flinn on the role of btk inhibitors in cll
-
1:06
dr. sharman on remaining challenges with btk inhibitors in cll
-
9:00
btk inhibitors in cll: ibrutinib
-
1:45
dr. ma on first- and second-generation btk inhibitors in b-cell malignancies
-
3:57
btk inhibitors in chronic lymphocytic leukemia
-
5:32
btk inhibitors in r/r cll
-
4:54
second-generation btk inhibitors in cll
-
1:28
dr. ma on the utility of btk inhibitors in relapsed/refractory cll
-
5:06
evolution of btk inhibitors in cll
-
1:22
dr. ghosh on unanswered questions with btk inhibitors in cll/sll
-
1:37
woyach on the safety profiles of btk inhibitors in cll
-
1:53
dr. kahl on frontline btk inhibitor selection in cll
-
0:57
dr. byrd on alacabrutinib's mechanism of action in cll
-
2:13
dr. tam discusses btk inhibition in cll
-
1:25:33
customizing care in cll with btk inhibitors
-
1:44
dr. furman on second-generation btk inhibitors in cll